Rare diseases
Investigational molecules
Locations
469 conditions with trials, the busiest first
1 123 trials across Europe, recruiting first
Study on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy on the Effectiveness of Paclitaxel, Docetaxel, and Oxaliplatin in Patients with Resectable Gastric Cancer
The NetherlandsStudy on Vedolizumab for Children with Moderate to Severe Ulcerative Colitis
BelgiumStudy on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease
AustriaStudy on Retreatment with Encorafenib and Cetuximab for Patients with BRAF V600E Mutated Metastatic Colorectal Cancer
ItalyStudy on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis
AustriaStudy on Bintrafusp Alfa with Chemoradiation for Patients with Esophageal Squamous Cell Carcinoma
The NetherlandsStudy on Tezepelumab for Symptom Relief in Patients Aged 12-80 with Eosinophilic Esophagitis
AustriaLong-term study of upadacitinib tablets for adults with Crohn's disease
DenmarkStudy comparing 177Lu-edotreotide versus everolimus in patients with inoperable progressive neuroendocrine tumors of gastroenteric or pancreatic origin
AustriaStudy on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis
AustriaStudy of Tofacitinib for Children with Moderate to Severe Ulcerative Colitis
BelgiumThe therapies tested most often in Gastrointestinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
